LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64 | -30.4% | 58,707 | +55.8% | 0.00% | 0.0% |
Q1 2023 | $92 | +91.7% | 37,689 | +50.4% | 0.00% | 0.0% |
Q4 2022 | $48 | -99.9% | 25,053 | -27.6% | 0.00% | 0.0% |
Q3 2022 | $83,000 | +25.8% | 34,589 | -2.5% | 0.00% | 0.0% |
Q2 2022 | $66,000 | -5.7% | 35,467 | +5.2% | 0.00% | 0.0% |
Q1 2022 | $70,000 | -10.3% | 33,720 | +69.9% | 0.00% | – |
Q4 2021 | $78,000 | -73.0% | 19,844 | -66.9% | 0.00% | -100.0% |
Q3 2021 | $289,000 | -24.9% | 59,992 | -28.5% | 0.00% | -50.0% |
Q2 2021 | $385,000 | +466.2% | 83,953 | +324.3% | 0.00% | – |
Q4 2020 | $68,000 | +54.5% | 19,786 | -11.1% | 0.00% | – |
Q2 2020 | $44,000 | +37.5% | 22,259 | +35.0% | 0.00% | – |
Q1 2020 | $32,000 | -84.5% | 16,492 | -1.7% | 0.00% | -100.0% |
Q3 2017 | $206,000 | -7.2% | 16,779 | +24.6% | 0.00% | 0.0% |
Q2 2017 | $222,000 | +8.3% | 13,466 | -5.7% | 0.00% | 0.0% |
Q1 2017 | $205,000 | -62.2% | 14,279 | -63.6% | 0.00% | -60.0% |
Q4 2016 | $543,000 | +290.6% | 39,255 | +237.0% | 0.01% | +400.0% |
Q1 2016 | $139,000 | +37.6% | 11,648 | +53.0% | 0.00% | 0.0% |
Q4 2015 | $101,000 | – | 7,611 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |